Cristina Serrano Castillo

Dr. Cristina Serrano Castillo


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2015 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
DSD. Subirá
D. Subirá
MSMarta Simó
Marta Simó
JIJ. Illán
J. Illán
CCCristina Serrano Castillo
Cristina Serrano Castillo
SCS. Castañón
S. Castañón
JBJordi Bruna
Jordi Bruna

8 September 2023 in Medicina
Verified
Journal Article
Open access
PDF file
CSCarlos Santonja
Carlos Santonja
DMDaniel Morillo
Daniel Morillo
EPElena Prieto-Pareja
Elena Prieto-Pareja
COCarlos Soto-De Ozaeta
Carlos Soto-De Ozaeta
CCCristina Serrano Castillo
Cristina Serrano Castillo
Socorro María Rodríguez-PinillaSocorro María Rodríguez-Pinilla
Socorro María Rodríguez-Pinilla
Anaplastic large cell lymphoma (ALCL) with leukaemic presentation (either ab initio or along the course of the disease) has been rarely reported. Irrespective of ALK expression in the neoplastic cells, it features a dismal prognosis. We report a rare case of leukaemic, small cell variant ALK-positive ALCL with 9-year survival in a young woman who was treated upfront with corticosteroids and standard chemotherapy, and review thoroughly the previously published cases. Such an unexpected, good outcome hints at the existence of different clinical subgroups in the leukaemic variant of ALK-positive ALCL.

13 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
CSCarlos Santonja
Carlos Santonja
DMDaniel Morillo
Daniel Morillo
EPElena Prieto-Pareja
Elena Prieto-Pareja
COCarlos Soto-De Ozaeta
Carlos Soto-De Ozaeta
CCCristina Serrano Castillo
Cristina Serrano Castillo
Socorro María Rodríguez-PinillaSocorro María Rodríguez-Pinilla
Socorro María Rodríguez-Pinilla
Anaplastic large cell lymphoma (ALCL) with leukemic presentation (either ab initio or along the course of the disease) has been rarely reported. Irrespective of ALK-status in the neoplastic cells, it features a dismal prognosis. We report a case of leukemic, ALK-positive ALCL with 9-year survival in a young woman who was treated upfront with corticosteroids and standard chemotherapy, and review thoroughly the previously published cases. Such an unexpected, good outcome hints at the existence of different clinical subgroups in the leukemic variant of ALCL.